Barroso-Sousa, R., Tyekucheva, S., Exman, P., Umeton, R., Hodi, F. S., Winer, E. P., … Tolaney, S. M. (2019). TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC). Mastology, 29(3), 5. https://doi.org/10.29289/259453942019v29s1g04